
How pharma CEO pay shifted for these 4 companies last year
Novo Nordisk had, for all intents and purposes, a very good year in 2024. So why did CEO Lars Fruergaard Jørgensen see a compensation increase only in line with inflation? For Big Pharma CEOs, compensation can swing drastically year to year — from base …